1. Home
  2. VCYT

VCYT

Veracyte Inc.

as 11-14-2024 12:38pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

Founded: 2006 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: N/A IPO Year: 2013
Target Price: $39.71 AVG Volume (30 days): 767.2K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.12 EPS Growth: N/A
52 Week Low/High: $18.61 - $41.43 Next Earning Date: 11-06-2024
Revenue: $425,331,000 Revenue Growth: 23.95%
Revenue Growth (this year): 24.73% Revenue Growth (next year): 10.12%

VCYT Daily Stock ML Predictions

Stock Insider Trading Activity of Veracyte Inc. (VCYT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
JONES EVAN/ FA VCYT Director Sep 19 '24 Sell $35.23 5,173 $182,262.90 0
Leite John VCYT Chief Commercial Officer-CLIA Sep 4 '24 Sell $29.78 5,479 $163,159.14 76,174

Share on Social Networks: